vs
Side-by-side financial comparison of Bunge Global (BG) and DaVita (DVA). Click either name above to swap in a different company.
Bunge Global is the larger business by last-quarter revenue ($4.9B vs $3.6B, roughly 1.4× DaVita). DaVita runs the higher net margin — 6.5% vs 1.9%, a 4.5% gap on every dollar of revenue. On growth, Bunge Global posted the faster year-over-year revenue change (22.2% vs 12.3%). Over the past eight quarters, Bunge Global's revenue compounded faster (11.3% CAGR vs 6.6%).
Bunge Global SA (BUN-ghee) is a global agribusiness and food company, incorporated in Geneva, Switzerland and headquartered in St. Louis, Missouri, United States.
DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
BG vs DVA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $4.9B | $3.6B |
| Net Profit | $95.0M | $234.2M |
| Gross Margin | 20.7% | — |
| Operating Margin | 1.8% | 15.5% |
| Net Margin | 1.9% | 6.5% |
| Revenue YoY | 22.2% | 12.3% |
| Net Profit YoY | -84.2% | 43.8% |
| EPS (diluted) | $-0.02 | $3.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $3.6B | ||
| Q4 25 | $4.9B | $3.6B | ||
| Q3 25 | $4.4B | $3.4B | ||
| Q2 25 | $4.0B | $3.4B | ||
| Q1 25 | $3.7B | $3.2B | ||
| Q4 24 | $4.0B | $3.3B | ||
| Q3 24 | $3.9B | $3.3B | ||
| Q2 24 | $3.7B | $3.2B |
| Q1 26 | — | $234.2M | ||
| Q4 25 | $95.0M | $234.2M | ||
| Q3 25 | $166.0M | $150.3M | ||
| Q2 25 | $354.0M | $199.3M | ||
| Q1 25 | $201.0M | $162.9M | ||
| Q4 24 | $602.0M | $259.3M | ||
| Q3 24 | $221.0M | $214.7M | ||
| Q2 24 | $70.0M | $222.7M |
| Q1 26 | — | — | ||
| Q4 25 | 20.7% | — | ||
| Q3 25 | 24.3% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 16.3% | — | ||
| Q4 24 | 27.0% | — | ||
| Q3 24 | 19.9% | — | ||
| Q2 24 | 17.8% | — |
| Q1 26 | — | 15.5% | ||
| Q4 25 | 1.8% | 15.5% | ||
| Q3 25 | 6.2% | 14.8% | ||
| Q2 25 | 12.3% | 15.9% | ||
| Q1 25 | 7.8% | 13.6% | ||
| Q4 24 | 18.3% | 17.2% | ||
| Q3 24 | 8.3% | 16.4% | ||
| Q2 24 | 2.8% | 15.9% |
| Q1 26 | — | 6.5% | ||
| Q4 25 | 1.9% | 6.5% | ||
| Q3 25 | 3.8% | 4.4% | ||
| Q2 25 | 8.8% | 5.9% | ||
| Q1 25 | 5.5% | 5.1% | ||
| Q4 24 | 15.0% | 7.9% | ||
| Q3 24 | 5.7% | 6.6% | ||
| Q2 24 | 1.9% | 7.0% |
| Q1 26 | — | $3.22 | ||
| Q4 25 | $-0.02 | $3.22 | ||
| Q3 25 | $0.84 | $2.04 | ||
| Q2 25 | $2.61 | $2.58 | ||
| Q1 25 | $1.48 | $2.00 | ||
| Q4 24 | $4.27 | $3.08 | ||
| Q3 24 | $1.56 | $2.50 | ||
| Q2 24 | $0.48 | $2.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.0B | $700.7M |
| Total DebtLower is stronger | $10.2B | $10.2B |
| Stockholders' EquityBook value | $15.9B | $-651.1M |
| Total Assets | $44.5B | $17.5B |
| Debt / EquityLower = less leverage | 0.64× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $700.7M | ||
| Q4 25 | $2.0B | $700.7M | ||
| Q3 25 | $3.2B | $736.5M | ||
| Q2 25 | $7.1B | $739.4M | ||
| Q1 25 | $3.9B | $511.9M | ||
| Q4 24 | $3.8B | $846.0M | ||
| Q3 24 | $3.0B | $1.1B | ||
| Q2 24 | $1.3B | $437.2M |
| Q1 26 | — | $10.2B | ||
| Q4 25 | $10.2B | $10.2B | ||
| Q3 25 | $11.1B | $10.2B | ||
| Q2 25 | $7.7B | $10.1B | ||
| Q1 25 | $5.4B | $9.6B | ||
| Q4 24 | $5.4B | $9.2B | ||
| Q3 24 | $5.4B | $9.3B | ||
| Q2 24 | $4.1B | $8.5B |
| Q1 26 | — | $-651.1M | ||
| Q4 25 | $15.9B | $-651.1M | ||
| Q3 25 | $15.8B | $-571.9M | ||
| Q2 25 | $10.9B | $-369.6M | ||
| Q1 25 | $10.6B | $-267.1M | ||
| Q4 24 | $9.9B | $121.1M | ||
| Q3 24 | $10.1B | $386.7M | ||
| Q2 24 | $10.0B | $632.9M |
| Q1 26 | — | $17.5B | ||
| Q4 25 | $44.5B | $17.5B | ||
| Q3 25 | $46.3B | $17.6B | ||
| Q2 25 | $31.2B | $17.5B | ||
| Q1 25 | $26.7B | $17.1B | ||
| Q4 24 | $24.9B | $17.3B | ||
| Q3 24 | $25.3B | $17.5B | ||
| Q2 24 | $24.4B | $17.0B |
| Q1 26 | — | — | ||
| Q4 25 | 0.64× | — | ||
| Q3 25 | 0.71× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 0.51× | — | ||
| Q4 24 | 0.54× | 75.76× | ||
| Q3 24 | 0.54× | 23.95× | ||
| Q2 24 | 0.41× | 13.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3B | — |
| Free Cash FlowOCF − Capex | $809.0M | — |
| FCF MarginFCF / Revenue | 16.6% | — |
| Capex IntensityCapex / Revenue | 11.0% | — |
| Cash ConversionOCF / Net Profit | 14.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-879.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $540.7M | ||
| Q3 25 | $854.0M | $841.5M | ||
| Q2 25 | $-1.1B | $324.2M | ||
| Q1 25 | $-285.0M | $180.0M | ||
| Q4 24 | $1.1B | $547.6M | ||
| Q3 24 | $1.3B | $810.4M | ||
| Q2 24 | $-1.5B | $798.8M |
| Q1 26 | — | — | ||
| Q4 25 | $809.0M | $395.3M | ||
| Q3 25 | $385.0M | $675.4M | ||
| Q2 25 | $-1.5B | $203.1M | ||
| Q1 25 | $-595.0M | $36.8M | ||
| Q4 24 | $564.0M | $377.0M | ||
| Q3 24 | $973.0M | $671.4M | ||
| Q2 24 | $-1.8B | $674.1M |
| Q1 26 | — | — | ||
| Q4 25 | 16.6% | 10.9% | ||
| Q3 25 | 8.8% | 19.7% | ||
| Q2 25 | -36.8% | 6.0% | ||
| Q1 25 | -16.2% | 1.1% | ||
| Q4 24 | 14.1% | 11.4% | ||
| Q3 24 | 25.1% | 20.6% | ||
| Q2 24 | -47.4% | 21.2% |
| Q1 26 | — | — | ||
| Q4 25 | 11.0% | 4.0% | ||
| Q3 25 | 10.7% | 4.9% | ||
| Q2 25 | 10.1% | 3.6% | ||
| Q1 25 | 8.5% | 4.4% | ||
| Q4 24 | 12.2% | 5.2% | ||
| Q3 24 | 9.1% | 4.3% | ||
| Q2 24 | 8.0% | 3.9% |
| Q1 26 | — | — | ||
| Q4 25 | 14.18× | 2.31× | ||
| Q3 25 | 5.14× | 5.60× | ||
| Q2 25 | -3.03× | 1.63× | ||
| Q1 25 | -1.42× | 1.10× | ||
| Q4 24 | 1.75× | 2.11× | ||
| Q3 24 | 6.00× | 3.77× | ||
| Q2 24 | -21.06× | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BG
| Other Oilseeds Processing And Refining | $4.6B | 95% |
| Other | $251.0M | 5% |
| Other Products | $3.0M | 0% |
DVA
Segment breakdown not available.
